Integrativesubtractive proteomics, immunoinformatics, docking, and simulation approaches reveal candidate vaccine against Sin Nombre orthohantavirus

Medicine and Dentistry

• Proteomics 100%
• Toll Like Receptor 4 100%
• Epitope 100%
• Binding Energy 50%
• Glycoprotein 50%
• Docking (Molecular) 25%
• Binding Affinity 25%
• Diseases 25%
• Receptor 25%
• Immune System 25%
• Precursor 25%
• Amino Acid 25%
• T Cell 25%
• Virus Infection 25%
• Bacterial Disease 25%

Biochemistry, Genetics and Molecular Biology

• Proteomics 100%
• TLR4 100%
• Binding Energy 50%
• Glycoprotein 50%
• Binding Affinity 25%
• Docking (Molecular) 25%
• Precursor 25%
• Molecular Weight 25%
• Amino Acid 25%
• T Cell 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Epitope 100%
• Toll Like Receptor 4 80%
• Glycoprotein 40%
• Diseases 20%
• Syndrome 20%
• Virus Infection 20%
• Receptor 20%
• Amino Acid 20%
• Multi-Epitope Vaccine 20%